FREE TRIAL UPGRADE!
Thank you for investing in EnvironmentalHazmatHuman ResourcesHuman Resources, Hazmat & Environmental related content. Click 'UPGRADE' to continue.
CANCEL
YOU'RE ALL SET!
Enjoy your limited-time access to the Compliance Network!
A confirmation welcome email has been sent to your email address from ComplianceNetwork@t.jjkellercompliancenetwork.com. Please check your spam/junk folder if you can't find it in your inbox.
YOU'RE ALL SET!
Thank you for your interest in EnvironmentalHazmatHuman ResourcesHuman Resources, Hazmat & Environmental related content.
WHOOPS!
You've reached your limit of free access, if you'd like more info, please contact us at 800-327-6868.
CLOSE
 
 

...

§382.213 Controlled substances use.

RegSenseFleet SafetyFederal Motor Carrier Safety Administration (FMCSA), DOTDrug testing - Motor CarrierDrug and Alcohol Testing - DOTFocus AreaCompliance DocsStandard InterpretationEnglishTransportationUSA

Question 1: Must a physician specifically advise that substances in a prescription will not adversely affect the driver’s ability to safely operate a CMV or may a pharmacist’s advice or precautions printed on a container suffice for the advice?

Guidance: A physician must specifically advise the driver that the substances in a prescription will not adversely affect the driver’s ability to safely operate a CMV.

['Drug and Alcohol Testing - DOT']
['Drug testing - Motor Carrier']
Load More